Project Number 5P50AG005134-34 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Mouse Model of Early Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Category F. Research Resources 6. Disease Models c. Rodents Researcher and Organization Principal Investigator HYMAN, BRADLEY T Principal Investigator First Name BRADLEY Principal Investigator Last Name HYMAN Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-019: Alzheimer's Disease Research Centers (P50) FY Overall Cost $222,281 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) Massachusetts General Hospital/Harvard Medical School Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy Pagination Page 1 Next page ››
